3,980 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2317560/treace-medical-concepts-tmci-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317560 Aug 06, 2024 - Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of -17.24% and 3.81%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Tidewater (TDW) Tops Q2 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2317559/tidewater-tdw-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317559 Aug 06, 2024 - Tidewater (TDW) delivered earnings and revenue surprises of 30.56% and 2.10%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Fuel Tech, Inc. (FTEK) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2317566/fuel-tech-inc-ftek-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317566 Aug 06, 2024 - Fuel Tech (FTEK) delivered earnings and revenue surprises of 50% and 21.21%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The RealReal (REAL) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2317540/the-realreal-real-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317540 Aug 06, 2024 - The RealReal (REAL) delivered earnings and revenue surprises of 13.33% and 3.64%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2317544/caribou-biosciences-inc-crbu-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317544 Aug 06, 2024 - Caribou Biosciences (CRBU) delivered earnings and revenue surprises of 6.67% and 4.56%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Airgain (AIRG) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2317546/airgain-airg-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317546 Aug 06, 2024 - Airgain (AIRG) delivered earnings and revenue surprises of 28.57% and 1.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
MBIA (MBI) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2317531/mbia-mbi-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317531 Aug 06, 2024 - MBIA (MBI) delivered earnings and revenue surprises of -3,122.22% and 6.90%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2317530/heron-therapeutics-hrtx-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317530 Aug 06, 2024 - Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -50% and 1.91%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Rivian tops Wall Street's second-quarter expectations amid cost cuts https://www.cnbc.com/2024/08/06/rivian-tops-second-quarter-earnings-expectations-following-cost-cuts.html Aug 06, 2024 - Rivian beat Wall Street's top- and bottom-line expectations for the second quarter as the electric vehicle maker continues to take costs out of its business.
Masimo (MASI) Tops Q2 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2317521/masimo-masi-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2317521 Aug 06, 2024 - Masimo (MASI) delivered earnings and revenue surprises of 11.69% and 0.24%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Pages: 1...8384858687888990919293...398

<<<Page 88>